CPA
TMO icon

Court Place Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Court Place Advisors’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$2.36M Sell
4,862
-79
-2% -$36.8K 0.71% 32
2025
Q2 		$2M Buy
4,941
+305
+7% +$128K 0.63% 37
2025
Q1 		$2.31M Sell
4,636
-114
-2% -$61.7K 0.77% 31
2024
Q4 		$2.47M Sell
4,750
-256
-5% -$141K 0.8% 30
2024
Q3 		$3.1M Sell
5,006
-10
-0.2% -$5.92K 0.9% 27
2024
Q2 		$2.77M Buy
5,016
+335
+7% +$192K 0.87% 28
2024
Q1 		$2.72M Sell
4,681
-420
-8% -$236K 0.88% 31
2023
Q4 		$2.71M Sell
5,101
-104
-2% -$50.3K 0.89% 30
2023
Q3 		$2.63M Sell
5,205
-40
-0.8% -$21.3K 0.94% 27
2023
Q2 		$2.74M Buy
5,245
+773
+17% +$417K 0.96% 27
2023
Q1 		$2.58M Sell
4,472
-130
-3% -$73.3K 0.93% 27
2022
Q4 		$2.53M Sell
4,602
-230
-5% -$122K 0.92% 28
2022
Q3 		$2.45M Sell
4,832
-20
-0.4% -$11.2K 0.99% 27
2022
Q2 		$2.64M Buy
4,852
+753
+18% +$414K 1% 26
2022
Q1 		$2.42M Sell
4,099
-180
-4% -$103K 0.78% 34
2021
Q4 		$2.85M Sell
4,279
-25
-0.6% -$15.6K 0.79% 37
2021
Q3 		$2.46M Sell
4,304
-90
-2% -$49.4K 0.73% 42
2021
Q2 		$2.22M Buy
4,394
+365
+9% +$172K 0.65% 45
2021
Q1 		$1.84M Buy
4,029
+575
+17% +$274K 0.57% 52
2020
Q4 		$1.61M Sell
3,454
-20
-0.6% -$9.38K 0.54% 51
2020
Q3 		$1.53M Hold
3,474
– – 0.57% 49
2020
Q2 		$1.26M Buy
3,474
+500
+17% +$168K 0.49% 54
2020
Q1 		$843K Sell
2,974
-30
-1% -$9.46K 0.38% 68
2019
Q4 		$976K Hold
3,004
– – 0.35% 72
2019
Q3 		$875K Sell
3,004
-15
-0.5% -$4.29K 0.34% 74
2019
Q2 		$887K Buy
3,019
+835
+38% +$230K 0.35% 71
2019
Q1 		$598K Hold
2,184
– – 0.24% 98
2018
Q4 		$489K Sell
2,184
-25
-1% -$5.87K 0.22% 96
2018
Q3 		$539K Hold
2,209
– – 0.2% 102
2018
Q2 		$458K Sell
2,209
-75
-3% -$15.9K 0.19% 105
2018
Q1 		$472K Buy
+2,284
New +$479K 0.2% 105

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Court Place Advisors's TMO Position: Q3 2025 in Review

Court Place Advisors reduced its Thermo Fisher Scientific (TMO) stake by 1.6% in Q3 2025, selling an estimated $36.8K and leaving 4,862 shares worth $2.36M. The position accounts for 0.71% of the portfolio, ranked #32.

Court Place Advisors first reported a position in TMO in Q1 2018 and has held it in 31 quarters since. The position peaked at $3.1M in Q3 2024. 2,509 funds tracked by Wall St. Rank hold TMO as of Q3 2025.

  • Court Place Advisors held 4,862 shares of Thermo Fisher Scientific worth $2.36M as of Q3 2025.
  • Court Place Advisors sold 79 Thermo Fisher Scientific shares in Q3 2025, an estimated $36.8K.
  • Thermo Fisher Scientific made up 0.71% of Court Place Advisors's portfolio in Q3 2025, its #32 holding.
  • Court Place Advisors first reported a position in Thermo Fisher Scientific in Q1 2018 and has held it in 31 quarters since.
  • Court Place Advisors's Thermo Fisher Scientific position peaked at $3.1M in Q3 2024.
  • 2,509 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2025.

Based on Court Place Advisors's 13F filing for Q3 2025, filed 25 Nov 2025.